Transgenic Mice as Models for Tumorigenesis

References

• Merlino G. Transgenic animals in biomedical research. FASEB J 1991; 5: 2996–3001
   PubMed Web of Science ®Google Scholar
• Adam J M, Cory S. Transgenic models of tumor development. Science 1991; 254: 1161–1167
   PubMed Web of Science ®Google Scholar
• Hanahan D. Dissecting multistep tumorigenesis in transgenic mice. Annu Rev Genet 1988; 22: 479–519
   PubMed Web of Science ®Google Scholar
• Jaenisch R. Transgenic animals. Science 1988; 240: 1468–1474
   PubMed Web of Science ®Google Scholar
• Hanahan D. Transgenic mice as probes into complex systems. Science 1989; 246: 1265–1275
   PubMed Web of Science ®Google Scholar
• Connelly C S, Fahl W E, Iannaccone P M. The role of transgenic animals in the analysis of various biological aspects of normal and pathologic states. Exp Cell Res 1989; 183: 257–276
   PubMed Web of Science ®Google Scholar
• Babinet C, Morello D, Renard J P. Transgenic animals. Genome 1989; 31: 938–949
   PubMed Web of Science ®Google Scholar
• Capecchi M R. Altering the genome by homologous recombination. Science 1989; 244: 1288–1292
   PubMed Web of Science ®Google Scholar
• Frohman M A, Martin G R. Cut, paste, and save: New approaches to altering specific genes in mice. Cell 1989; 56: 145–147
   PubMed Web of Science ®Google Scholar
• Varmus H. An historical overview of oncogenes. Oncogenes and the Molecular Origins of Cancer, RA Weinberg. Cold Spring Harbor Laboratory Press, New York 1989; 3–44
   Google Scholar
• Bishop J M. Molecular themes in oncogenesis. Cell 1991; 64: 235–248
   PubMed Web of Science ®Google Scholar
• Dickson R B, Gottardis M M, Merlino G T. Molecular insights into breast cancer from transgenic mouse models. Bio Essays 1991; 13: 1–6
   PubMedGoogle Scholar
• Stewart T A, Pattengale P K, Leder P. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 1984; 38: 627–637
   PubMed Web of Science ®Google Scholar
• Schoenenberger C A, Andres A C, Groner B, Van der Valk M, LeMeur M, Gerlinger P. Targeted c-myc gene expression in mammary glands of transgenic mice induces mammary tumours with constitutive milk protein gene transcription. EMBO J 1988; 7: 169–175
   PubMed Web of Science ®Google Scholar
• Andres A C, Van der Valk M A, Schwnenberger C A, Fluckiger F, LeMeur M, Gerlinger P, Groner B. Ha-ras and c-myc oncogene expression interferes with morphological and functional differentiation of mammary epithelial cells in single and double transgenic mice. Genes Dev 1988; 2: 1486–1495
   PubMed Web of Science ®Google Scholar
• Sinn E, Muller W, Pattengale P, Tepler I, Wallace R, Leder P. Coexpression of MMTV/v-Ha-ras and MMTVlc-myc genes intransgenic mice: Synergistic action of oncogenes in vivo. Cell 1987; 49: 465–475
   PubMed Web of Science ®Google Scholar
• Andres A C, Schwnenberger C A, Groner B, Henninghausen L, LeMeur M, Gerlinger P. Ha-ras oncogene expression directed by a milk protein gene promoter: Tissue specificity, hormonal regulation, and tumor induction in transgenic mice. Proc Natl Acad Sci USA 1987; 84: 1299–1303
   PubMed Web of Science ®Google Scholar
• Muller W J, Sinn E, Pattengale P K, Wallace R, Leder P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 1988; 54: 105–115
   PubMed Web of Science ®Google Scholar
• Bouchard L, Lamarre L, Tremblay P J, Jolicoeur P. Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Cell 1989; 57: 931–936
   PubMed Web of Science ®Google Scholar
• Suda Y, Aizawa S, Furuta Y, Yagi T, Lkawa Y, Saitoh K, Yamada Y, Toyoshima K, Yamamoto T. Induction of a variety of tumors by c-erbB2 and clonal nature of lymphomas even with the mutated gene (Val659-Glu659). EMBO J 1990; 9: 181–190
   PubMed Web of Science ®Google Scholar
• Jhappan C, Stahle C, Harkins R N, Fausto N, Smith G H, Merlino G T. TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 1990; 61: 1137–1146
   PubMed Web of Science ®Google Scholar
• Sandgren E P, Luetteke N C, Palmiter R D, Brinster R L, Lee D C. Overexpression of TGFα in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 1990; 61: 1121–1135
   PubMed Web of Science ®Google Scholar
• Matsui Y, Halter S A, Holt J T, Hogan B LM, Coffey R J. Development of mammary hyperplasia and neoplasia in MMTV-TGFα transgenic mice. Cell 1990; 61: 1147–1155
   PubMed Web of Science ®Google Scholar
• Tsukamoto A S, Grosschedl R, Guzman R C, Parslow T, Varmus H E. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 1988; 55: 619–625
   PubMed Web of Science ®Google Scholar
• Jhappan C, Gallahan D, Stahle C, Chu E, Smith G H, Merlino G, Callahan R. Expression of an activated Notch-related int-3 trans-gene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. Genes Dev 1992; 6: 345–355
   PubMed Web of Science ®Google Scholar
• Sandgren E P, Quaife C J, Pinkert C A, Palmiter R D, Brinster R L. Oncogene-induced liver neoplasia in transgenic mice. Oncogene 1989; 4: 715–724
   PubMed Web of Science ®Google Scholar
• Efrat S, Teitelman G, Anwar M, Ruggiero D, Hanahan D. Glucagon gene regulatory region directs oncoprotein expression to neurons and pancreatic alpha cells. Neuron 1988; 1: 605–613
   PubMed Web of Science ®Google Scholar
• Quaife C J, Pinkert C A, Ornitz D M, Palmiter R D, Brinster R L. Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice. Cell 1987; 48: 1023–1034
   PubMed Web of Science ®Google Scholar
• Sandgren E P, Quaife C J, Paulovich A G, Palmiter R D, Brinster R L. Pancreatic tumor pathogenesis reflects the causative genetic lesion. Proc Natl Acad Sci USA 1991; 88: 93–97
   PubMed Web of Science ®Google Scholar
• Hanahan D. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulinkirnian virus 40 oncogenes. Nature 1985; 315: 115–122
   PubMed Web of Science ®Google Scholar
• Adam J M, Harris A W, Pinkert C A, Corcoran L M, Alexander W S, Cory S, Palmiter R D, Brinster R L. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 1985; 318: 533–538
   PubMed Web of Science ®Google Scholar
• Schmidt E V, Pattengale P K, Weir L, Leder P. Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: A pre-B-cell lymphoma model. Proc Natl Acad Sci USA 1988; 85: 6047–6051
   PubMed Web of Science ®Google Scholar
• Suda Y, Aizawa S, Hirai S, Lnoue T, Furuta Y, Suzuki M, Hirohashi S, Ikawa Y. Driven by the same Ig enhancer and SV40 T promoter ras induced lung adenomatous tumors. myc induced pre-B cell lymphomas and SV40 large T gene a variety of tumors in transgenic mice. EMBO J 1987; 6: 4055–4065
   PubMed Web of Science ®Google Scholar
• Spanopoulou E, Early A, Elliott J, Crispe N, Ladyman H, Ritter M, Watt S, Grosveld F, Kioussis D. Complex lymphoid and epithelial thymic turnours in Thyl-myc transgenic mice. Nature 1989; 342: 185–189
   PubMed Web of Science ®Google Scholar
• Garvin A M, Abraham K M, Forbush K A, Farr A G, Davison B L, Perlmutter R M. Disruption of thymocyte development and lymphomagenesis induced by SV40 T-antigen. Int lmmunol 1990; 2: 173–180
   PubMed Web of Science ®Google Scholar
• Weinberg R A. Tumor suppressor genes. Science 1991; 254: 1138–1146
   PubMed Web of Science ®Google Scholar
• Marshall C J. Tumor suppressor genes. Cell 1991; 64: 313–326
   PubMed Web of Science ®Google Scholar
• Levine A J, Momand J, Finlay C A. The p53 tumor suppressor gene. Nature 1991; 351: 453–456
   PubMed Web of Science ®Google Scholar
• Lavigueur A, Maltby V, Mock D, Rossant J, Pawson T, Bernstein A. High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol Cell Biol 1989; 9: 3982–3991
   PubMed Web of Science ®Google Scholar
• Donehower L A, Harvey M, Slagle B L, McArthur M I, Montgomery C A, Butel J S, Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992; 356: 215–221
   PubMed Web of Science ®Google Scholar
• Knudson A G. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971; 68: 820–823
   PubMed Web of Science ®Google Scholar
• Jacks T, Fazeli A, Schmitt E M, Bronson R T, Goodell M A, Weinberg R A. Effects of an Rb mutation in the mouse. Nature 1992; 359: 295–300
   PubMed Web of Science ®Google Scholar
• Lee E YHP, Chang C Y, Hu N, Wane Y CJ, Lai C C, Herrup K, Lee W H, Bradley A. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 1992; 359: 288–294
   PubMed Web of Science ®Google Scholar
• Clarke A R, Maandag E R, Van Roon M, Van der Lugt M T, Van der Valk M, Hooper M L, Berns A, Te Riele H. Requirement for a functional Rb-l gene in murine development. Nature 1992; 359: 328–330
   PubMed Web of Science ®Google Scholar
• Hunter T. Cooperation between oncogenes. Cell 1991; 64: 249–270
   PubMed Web of Science ®Google Scholar
• Langdon W Y, Harris A W, Cory S, Adams J M. The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic mice. Cell 1986; 47: 11–18
   PubMed Web of Science ®Google Scholar
• Barbacid M. ras genes. Annu Rev Biochem 1987; 56: 779–827
   PubMed Web of Science ®Google Scholar
• Solomon E, Borrow J, Goddard A D. Chromosome aberations and cancer. Science 1991; 254: 1153–1160
   PubMed Web of Science ®Google Scholar
• McDonnell T J, Korsmeyer S J. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the 1(14:18). Nature 1991; 349: 254–256
   PubMed Web of Science ®Google Scholar
• Heisterkamp N, Jenster G, Ten Hoeve J, Zovich D, Pattengale P, Groffen K. J. Acute leukaemia in bcr/abl transgenic mice. Nature 1990; 344: 251–253
   PubMed Web of Science ®Google Scholar
• Vogel J, Hinrichs S H, Reynolds R K, Luciw P A, Jay G. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 1988; 335: 606–611
   PubMed Web of Science ®Google Scholar
• Leonard J M, Abramczuk J W, Pezen D S, Rutledge R, Belcher J H, Hakim F, Shearer G, Lamperth L, Travis W, Fredrickson T, Notkins A L, Martin M A. Development of disease and virus recovery in transgenic mice containing HIV proviral DNA. Science 1988; 242: 1665–1670
   PubMed Web of Science ®Google Scholar
• Chisari F V, Klopchin K, Moriyama T, Pasquinelli C, Dunsford H A, Sell S, Pinkerl C A, Brinster R L, Palmiter R D. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 1989; 59: 1145–1156
   PubMed Web of Science ®Google Scholar
• Kim C M, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991; 351: 317–320
   PubMed Web of Science ®Google Scholar
• Sell S, Hunt J M, Dunsford H A, Chisari F V. Synergy between hepatitis B virus expression and chemical hepatocarcinogenesis in transgenic mice. Cancer Res 1991; 51: 1278–1285
   PubMed Web of Science ®Google Scholar
• Breuer M, Slebos R, Verbeek S, Van Lohuizen M, Wientjens E, Berns A. Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice. Nature 1989; 340: 61–63
   PubMed Web of Science ®Google Scholar
• Breuer M, Wientjens F, Verbeek S, Slebos R, Berns A. Carcinogen-induced lymphomagenesis inpim-1 transgenic mice: Dose dependence and involvement of myc and ras. Cancer Res 1991; 51: 958–963
   PubMed Web of Science ®Google Scholar
• Guy C T, Cardiff R D, Muller W J. Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease. Mol Cell Biol 1992; 12: 954–961
   PubMed Web of Science ®Google Scholar
• Bailleul B, Surani M A, White S, Barton S C, Brown K, Blessing M, Jorcano J, Balmain A. Skin hyperkeratosis and a papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter. Cell 1990; 62: 697–708
   PubMed Web of Science ®Google Scholar
• Vassar R, Fuchs E. Transgenic mice provide new insights into the role of TGFα during epidermal development and differentiation. Genes Dev 1991; 5: 714–727
   PubMed Web of Science ®Google Scholar
• Field L J. Atrial natriuretic factor-SV40 T antigen transgenes produce tumors and cardiac arrhythmias in mice. Science 1988; 239: 1029–1033
   PubMed Web of Science ®Google Scholar
• Behringer R R, Peschon J J, Messing A, Gartside C L, Hauschka S D, Palmiter R D, Brinster R L. Heart and bone tumors in transgenic mice. Proc Natl Acad Sci USA 1988; 85: 2648–2652
   PubMed Web of Science ®Google Scholar
• Mahon K A, Chepelinsky A B, Khillan J S, Overbeek P A, Piatigorsky J, Westphal H. Oncogenesis of the lens in transgenic mice. Science 1987; 235: 1622–1628
   PubMed Web of Science ®Google Scholar
• Windle J J, Albert D M, O'Brien J M, Marcus D M, Disteche C M, Bernards R, Mellon P L. Retinoblastoma in transgenic mice. Nature 1990; 343: 665–669
   PubMed Web of Science ®Google Scholar
• Koike K, Hinrichs S H, Lsselbacher KJ, Jay G. Transgenic mouse model for human gastric carcinoma. Proc Natl Acad Sci USA 1989; 86: 5615–5619
   PubMed Web of Science ®Google Scholar
• Knowles B B, McCarrick J, Fox N, Solter D, Damjanov I. Osteosarcomas in transgenic mice expressing an alpha-amylase-SV40 T-antigen hybrid gene. Am J Pathol 1990; 137: 259–262
   PubMed Web of Science ®Google Scholar
• Windle J J, Weiner R I, Mellon P L. Cell lines of the pituitary gonadotrope lineage derived by targeted oncogenesis in transgenic mice. Mol Endocrinol 1990; 4: 597–603
   PubMed Web of Science ®Google Scholar
• Kwan H, Pecenka V, Tsukamoto A, Parslow T G, Guzman R, Lin T P, Muller W J, Lee F S, Leder P, Varmus H E. Transgenes expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice. Mol Cell Biol 1992; 12: 147–154
   PubMed Web of Science ®Google Scholar
• Verbeek S, Van Lohuizen M, Van der Valk M, Domen J, Kraal G, Berns A. Mice bearing the Eμ-myc and Eμ-pim-1 transgenes develop pre-B-cell leukemia prenatally. Mol Cell Biol 1991; 11: 1176–1179
   PubMed Web of Science ®Google Scholar
• Rosenbaum H, Harris A W, Bath M L, McNeall J, Webb E, Adams J M, Cory S. An Eμ-abl transgene elicits plasmacytomas in concert with an activated myc gene. EMBO J 1990; 9: 897–905
   PubMed Web of Science ®Google Scholar
• Strasser A, Harris A W, Bath M L, Cory S. Novel primitive lym-phoid turnours induced in transgenic mice by cooperation between myc and bcl-2. Nature 1985; 348: 331–333
   Google Scholar
• Murakami H, Sanderson N D, Nagy P, Marino P A, Merlino G, Thorgeirsson S S. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: Inter action of c-myc and transforming growth factor a in hepatic on-cogenesis. Cancer Res 1993; 53: 1719–1723
   PubMed Web of Science ®Google Scholar
• Hogan B, Costantini F, Lacy E. Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor Laboratory Press, New York 1986
   Google Scholar
• Sandgren E P, Luetteke N C, Qiu T H, Palmiter R D, Brinster R L, Lee D C. Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver. Mol Cell Biol 1993; 13: 320–330
   PubMed Web of Science ®Google Scholar